Analyst Price Target is $67.67
▲ +83.13% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Establishment Labs in the last 3 months. The average price target is $67.67, with a high forecast of $105.00 and a low forecast of $47.00. The average price target represents a 83.13% upside from the last price of $36.95.
Current Consensus is
The current consensus among 6 contributing investment analysts is to buy stock in Establishment Labs. This Buy consensus rating has held steady for over two years.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.